Učitavanje...
Daratumumab and antineoplastic therapy versus antineoplastic therapy only for people with newly diagnosed multiple myeloma ineligible for transplant
This is a protocol for a Cochrane Review (intervention). The objectives are as follows: This review aims to determine benefits and harms of daratumumab in addition to antineoplastic therapy compared to antineoplastic therapy only for adults with newly diagnosed multiple myeloma ineligible for transp...
Spremljeno u:
| Izdano u: | Cochrane Database Syst Rev |
|---|---|
| Glavni autori: | , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
John Wiley & Sons, Ltd
2020
|
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7197647/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD013595 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|